Eyelash growth is a phenomenon associated with Bimatoprost ophthalmic solution 0.03%. The US food and drug administration approves the eye drops for ocular hypertension and glaucoma treatment. The ophthalmic preparation may also prolong the growth phase of eyelashes, leading to an increase in eyelash length, thickness, and darkness.
Bimatoprost eye drop 0.03% has been successfully used for many years in the treatment of glaucoma. It is a prostamide analogue primarily used to reduce intraocular pressure in patients with ocular hypertension and glaucoma. The food and drug administration approved the pharmaceutical ingredient in the form of eye drop for treating patients with open-angle glaucoma and ocular hypertension. Lowering elevated pressure inside the eye may prevent vision loss. This medicine is extremely beneficial at regulating the fluid flow within the eye to able to maintain normal eye pressure. Enhanced eyelash prominence was observed in these patients as a side effect while examining the effectiveness of Bimatoprost drops as an ocular hypertensive agent. This finding led to the formation of Bimatoprostas an effective treatment for eyelash hypotrichosis (inadequate eyelashes). The application of these eye drops to the upper lash line once before bed increase eyelash growth along with a significant increase in eyelash thickness and darkness. It promotes eyelash growth of healthy as well as thin eyelashes. The product is generally safe when applied to the base of the upper lash line. However, side effects associated with this eye care solution may occur when it meets the surface of the eyes and patients must be aware of the unwanted hair growth as an adverse effect of ophthalmic preparation. When used in glaucoma patients, the pharmaceutical ingredients have a favourable safety and tolerability profile. Use this medication regularly to get the desired results. It may take up to two months before a noticeable change is seen.
